Fidelity Investments’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
FLAM
Fidelity Investments's WGS Position: Q2 2026 in Review
Fidelity Investments reduced its GeneDx Holdings (WGS) stake by 98% in Q2 2026, selling an estimated $16.4M and leaving 7,132 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #3292.
Fidelity Investments first reported a position in WGS in Q3 2021 and has held it in 20 quarters since. The position peaked at $247M in Q1 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.
- Fidelity Investments held 7,132 shares of GeneDx Holdings worth $490K as of Q2 2026.
- Fidelity Investments sold 288,489 GeneDx Holdings shares in Q2 2026, an estimated $16.4M.
- GeneDx Holdings made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3292 holding.
- Fidelity Investments first reported a position in GeneDx Holdings in Q3 2021 and has held it in 20 quarters since.
- Fidelity Investments's GeneDx Holdings position peaked at $247M in Q1 2025.
- 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.